The global Muscle Stimulator Market size is estimated to reach ~USD 2 Billion by the end of 2035 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2035. In addition to this, in the year 2022, the market size of muscle stimulator was ~USD 1 Billion. The growth of the market can be attributed to the increasing rates of arthritis among the global population. In recent years, individuals have become increasingly sedentary, which increases the chance of developing arthritis. Adult impairment is most commonly caused by arthritis. For instance, arthritis can cause persistent discomfort, making it difficult to carry out everyday tasks. Electric muscle stimulators are employed to treat rheumatoid arthritis's chronic discomfort, retrain muscles, and build up the muscles that support their weaker joints. Hence, with the rising cases of arthritis is expected to increase the utilization rate of muscle stimulator and aid in the expansion of the global market. As per estimates, arthritis affects more than 300 million individuals worldwide.
In addition to these, factors that are believed to fuel the market growth of muscle stimulator include the rising adoption of muscle stimulator by physiotherapists. In order to treat pain and muscle spasms, electrical stimulation is utilized by physical therapists. Further, as muscle stimulators are speedier and more effective than manual methods, they are becoming more and more used among physiotherapists as a therapy option for patients in clinical and home care settings. For instance, muscle stimulator enables the physiotherapist to treat and prevent a variety of patient diseases and injuries.
Base Year |
2022 |
Forecast Year |
2023-2035 |
CAGR |
~6% |
Base Year Market Size (2022) |
~ USD 1 Billion |
Forecast Year Market Size (2035) |
~ USD 2 Billion |
Regional Scope |
|
Growth Drivers
Challenges
The global market of muscle stimulator is segmented and analyzed for demand and supply by product into transcutaneous electrical nerve stimulator, burst mode alternating current, neuromuscular electric stimulation, and interferential current. Out of these segments, the transcutaneous electrical nerve stimulator segment is estimated to gain the largest market share of about ~38% in the year 2035. The growth of the segment can be attributed to the increasing prevalence of rheumatoid arthritis. A chronic, systemic, inflammatory condition known as rheumatoid arthritis (RA) primarily affects the synovial membranes of many bodily joints, most likely caused by a mix of genetic predisposition, numerous environmental circumstances, and a person's lifestyle. Inflammatory arthritis, such as rheumatoid arthritis, may also be treated using transcutaneous electrical nerve stimulator (TENS). As part of an arthritis self-management plan, it is affordable, safe, and simple to use. Further, the discomfort associated with rheumatoid arthritis is frequently managed by transcutaneous electrical nerve stimulation. According to estimates, rheumatoid arthritis affects approximately 1% of people globally.
The global market is also segmented and analyzed for demand and supply by application into pain management, and muscle rehabilitation. Amongst these segments, the pain management segment is expected to garner a significant share of around ~46% in the year 2035. Aches in the muscles are a common occurrence in all ages and occupations, which can result from a known injury, illness, or a medical procedure. Additionally, acute pain may result from injuries such as cuts, burns, muscle strains, and others, whereas chronic pain can be caused by disease such as arthritis or cancer. Further, muscle stimulators are being used more often to treat both acute and long-term pain. For instance, transcutaneous electrical nerve stimulation (TENS) is a low-cost nonpharmacological therapy for acute and chronic pain disorders. TENS units send electrical impulses that block pain by resembling the nervous system's pain signals.
Our in-depth analysis of the global Muscle Stimulator Market includes the following segments:
By Application |
|
By Product |
|
By End User |
|
By Modality |
|
The market share of muscle stimulator in North America, amongst the in all the other regions, is projected to be the largest with a share of about ~35% by the end of 2035. Owing to growing aging population of US, musculoskeletal diseases are becoming a greater burden every year. Elderly people are more prone to musculoskeletal diseases and injuries. The most common musculoskeletal problems prevalent in the area are osteoporosis, which increases the risk of fractures, back and neck discomfort, injuries from sports, arthritis and other activities. The quality of life, activity level, and productivity can all be negatively impacted by musculoskeletal disorders that affect the bones, joints, and muscles. Further, many excruciating musculoskeletal illnesses are treated by electrical muscle stimulation. For instance, individuals with musculoskeletal disorders may benefit from using percutaneous electrical nerve stimulation (PENS) as a rehabilitation strategy to reduce mixed chronic pain in patients with musculoskeletal disorders. According to data, musculoskeletal ailment affects more than 120 million Americans.
The Asia Pacific Muscle Stimulator Market is estimated to be the second largest, registering a share of about ~24% by the end of 2035. The growth of the market can be attributed majorly to the growing understanding of electric muscle stimulator in the region. For instance, rising concern for health and fitness in the area has surged the demand for electric muscle stimulator. EMS training uses a spectrum of electric currents to trigger muscular contractions. Further, active exercise can be substituted by electrical muscle stimulation (EMS), which doesn't require patient involvement. By raising the demand for oxygen, electrical stimulation of unloaded muscles induces cardiovascular activity. Further, electrical stimulation training has been found to increase muscular strength and endurance. For instance, Ab stimulators, which is a kind of muscle stimulator uses electricity to provide the appearance of tighter, more toned abdominal muscles. Recently, in India, several gyms are using EMS equipment, as it is practical, safe, and non-intrusive.
Further, the market in the European region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The increasing number of the population suffering from lifestyle disorders coupled with the presence of the highly developed machines and devices is expected to be the major factor increasing the growth of the orthopedic prosthetic devices market in the region. The rising industrial development in the region leads to the development of the enhanced healthcare infrastructure coupled with stringent government policies regarding the healthcare is anticipated to drive the growth of the global orthopedic prosthetic devices market in the region.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increasing cases of musculoskeletal conditions and the growing rate of sports injuries are the major factors driving the market growth.
Ans: The market size of muscle stimulator is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2035.
Ans: Absence of regulations regarding the use of muscle stimulators and the exorbitant cost of muscle stimulator devices are estimated to be the growth hindering factors for the market expansion.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Boston Scientific Corporation, NeuroMetrix, Inc., OMRON Corporation, BioMedical Life Systems Inc., Zynex, Inc., EMS Physio Ltd., Beurer GmbH, Just Fitter, EMS Physio Ltd., RS Medical, Inc., and other key players.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by application, modality, product, end user, and by region.
Ans: The transcutaneous electrical nerve stimulator segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)